The higher-amount group saw average increases of 30% to 35% in red blood cells, plasma, and lymphocytes after six months
Ghanem H, Kantarjian HM, Ravandi F, Cortes JE, Pemmaraju N, Faderl S, Dellasala SE, O'Brien SM, Burger JA, Borthakur G , Kadia TM, Quints-Cardama A, Brandt M, Pierce SA, Garcia-Manero G, Jabbour EJ
The compound has been shown in cell-based research to upregulate VEGFR2 transcript levels, increase phosphorylation of downstream signalling intermediates after VEGF stimulation, and enhance endothelial tube formation in matrigel assays
Would these same mechanisms and suggestions also apply to fibroids in the breast